Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Tandem ...

Tandem Diabetes Care, Inc. price | Tandem Diabetes Care, Inc. Quote Tandem Diabetes seeks to grow its business through the acquisitions of products or technologies or investments in businesses. Last ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following ...